Analysis of the immunomodulatory effects of Echinacea

Phase 2

Completed

• Conditions: Immune system response; Alternative and Complementary Medicine - Herbal remedies; Inflammatory and Immune System - Normal development and function of the immune system

• Registration Number: ACTRN12609000417280
• Lead Sponsor: MediHerb Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy individuals exhibiting no sign of respiratory illness in the 2 weeks before the trial commences.

Exclusion Criteria

Plant/pollen allery
Lactation or pregnancy
Diagnosed respiratory disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood analysis of white blood cell types, heat chock protein expression levels and alkylamide concentrations will be assessed[Baseline and on completion of the 2 week supplementation period]

Secondary Outcome Measures

Name	Time	Method
Single dose pharmacokinetics will be examined in blood before and after the supplementation period.[Before and after the 2 weeks supplementation period]